EFTA00026794.pdf
- Type
- pdf
- Source set
- data-set-8
Original source
Extracted text
From: '
To:'
Cc: '
Subject: Re: Epstein investigation
Date: Sat, 22 Feb 2020 20:35:20 +0000
r<
<
On Feb 22, 2020, at 2:17 PM,
Sent from my iPhone
Begin forwarded message:
From: Jill Greenfield
Date: Februa
22 2020 at 1:55:06 PM EST
To: '
1" -
Cc: K le Philli
Subject: RE: Epstein investigation
Louise Scott
wrote:
Hello
Apologies for the slight delay. My client is willing to help but asks the following:
•
That there be a morning meeting at which introductions with a discussion as to the investigation and my clients
involvement. I appreciate that you have explained this to me but I think further verbal clarification would assist.
•
In the afternoon and after a break, my client would be willing to answer questions, in so far as she can.
•
That a friend of hers be allowed to be present as well. However that friend is based in the US and would need
to be flown over to London. He is a US lawyer.
Perhaps you could let me know if this is possible?
Kind regards,
Jill
Jill Greenfield
Partner
0:
M: MIN
Personal Injury Team of the Year - Solicitors Journal Awards 2017
EFTA00026794
l'icIdlisher
From:
Sent: Saturday, February 15, 2020 7:08 PM
To: Jill Greenfield
Cc: Kyle Phillips
Subject: RE: Epstein investigation
Understood — thanks very much.
IM•
From: Jill Greenfield
Sent: Saturday, February 15, 2020 07:22
To:1
Cc: Kyle Phillips <
>; Louise Scott <
I <
Subject: Re: Epstein investigation
Thanks=
This is helpful. I've gone back to my client with this. I will be back in touch shortly.
Regards
Jill
; Louise Scott <
Jill Greenfield
Partner
M:
Personal Injury Team of the Year - Solicitors Journal Awards 2017
kimage001.jpel
Sent from my iPhone
On 14 Feb 2020, at 21:43,
Jill,
M
S)
> wrote:
Following up on our phone call, thank you for talking with us again, and we wanted to get back to you regarding
some of the additional follow-up questions you asked, and to describe in more detail for your client how we would
expect…
Open in the interactive archive →